NHS Logo
Image from Google Jackets

Evidence-based management of lipid disorders [E-Book]

Contributor(s): Publisher: Harley : TFM, 2010Description: 1 online resource (326 pages) : illustrations (chiefly color)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781908986597
  • 190898659X
Subject(s): NLM classification:
  • 2010 I-616
  • WD 200.5.H8
  • WD 200.5.H8
Online resources:
Contents:
How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Despr�es -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library (Kingston Hospital) Online Link to resource Available

Includes bibliographical references and index.

Print version record.

How much evidence is enough? / Daniel Steinberg -- A brief review of lipoprotein metabolism / Martin Adiels [and others] -- Epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases / Jane Armitage, Louise Bowman, Sarah Lewington -- Are LDL cholesterol-lowering functional food ingredients successful in the long term? / Jogchum Plat, Ronald P. Mensink -- Evidence-based treatment of primary hypo- and hypercholesterolemic disorders / Tisha R. Joy, Robert A. Hegele -- Does raising HDL protect against atherosclerosis? / Menno Vergeer, G. Kees Hovingh -- How do we diagnose hypertriglyceridemia in clinical practice and what are the consequences for treatment? / Adie Viljoen, Anthony S. Wierzbicki -- The optimal treatment of patients with familial combined hyperlipidemia / Evertine J. Abbink, Jacqueline de Graaf, Anton F. Stalenhoef -- How to manage lipid and lipoprotein disorders in children / Serena Tonstad -- Contribution of the atherogenic dyslipidemic phenotype to the increased cardiovascular disease risk of the metabolic syndrome and diabetes mellitus / Benoit J. Arsenault, Jean-Pierre Despr�es -- What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels? / Christiane Drechsler, Christoph Wanner, Ton Rabelink -- The link between chronic inflammatory diseases and cardiovascular risk / Michael T. Nurmohamed -- What is the evidence for a physiological and pathogenic role of lipoprotein (a)? / Sotirios Tsimikas -- Sitosterolemia; xenophobia for the body / Shailendra B. Patel, Gerald Salen -- How can we deal with inborn errors in cholesterol and bile acid biosynthesis? / Hester van Meer [and others] -- Differential diagnosis of patients with xanthomas and xanthelasmata / Peter J. Lansberg -- When should we fear statin interactions? / Rob E. Aarnoutse, David M. Burger -- What are the considerations in patients who are statin 'intolerant'? / Frans L. Opdam, Henk-Jan Guchelaar, Jouke T. Tamsma.

There are no comments on this title.

to post a comment.
London Health Libraries Consortium Privacy notice and Membership terms and conditions